Sadhana Nitro Chem Capital Structure Change
Sadhana Nitro Chem Ltd received trading approvals from BSE and NSE for 6,75,00,000 equity shares. These shares were issued to non-promoters on a preferential basis.
- Value
- ₹13.91 Cr
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
29 announcements with these filters
Sadhana Nitro Chem Ltd received trading approvals from BSE and NSE for 6,75,00,000 equity shares. These shares were issued to non-promoters on a preferential basis.
Sadhana Nitrochem Limited issued the notice for its 53rd AGM on 30 September 2026 via VC/OAVM. The filing includes the Annual Report for FY 2025-26 and detailed e-voting schedule.
Sadhana Nitro Chem Ltd has filed its shareholding pattern for the quarter ended June 30, 2026, as per regulatory requirements.
Niraj Bajaj acquired 5.25 crore shares of Sadhana Nitrochem Ltd via a preferential allotment. This increases his stake from 4.98% to 6.60%.
Sadhana Nitro Chem Limited submitted its Monitoring Agency Report for the quarter ended June 30, 2026. The report confirms no deviation in fund utilization.
Sadhana Nitro Chem Ltd reported revenue from operations of ₹27.2 Cr (-3.2% YoY) and a net loss of ₹0.6 Cr for Q1 FY27.
Sadhana Nitro Chem Limited scheduled a board meeting for August 07, 2026, to consider and approve its unaudited financial results for the quarter ended June 30, 2026.
Sadhana Nitro Chem received in-principle approval from BSE and NSE for a proposed preferential issue of 6,75,00,000 equity shares. The approval facilitates the upcoming capital raise.
Sadhana Nitro Chem Ltd reported revenue from operations of ₹28.1 Cr (-22.2% YoY) and a net loss of ₹2.1 Cr for Q1 FY26.
Sadhana Nitro Chem clarified the pricing for its ₹13.91 Crore preferential allotment of 6.75 Crore shares. The issue price is fixed at ₹2.06 per equity share.
Sadhana Nitro Chem Limited filed its Annual Secretarial Compliance Report for FY26. The report details several regulatory non-compliances and resulting fines totaling ₹0.07 Crore.
Sadhana Nitro Chem secured a ₹108 Crore speciality chemical export contract from a Japanese multinational. This two-year agreement boosts the confirmed order book above ₹200 Crore.
Sadhana Nitrochem appointed M/s. Chandrasekhar Iyer & Co as Internal Auditors and M/s. Vinay Mulay & Co as Cost Auditors. These twelve-month appointments strengthen the company's regulatory oversight.
Sadhana Nitrochem's board did not recommend a final dividend for the period due to losses. Investors should note the lack of payout despite the board meeting discussion.
Sadhana Nitro Chem Limited confirmed no deviations in utilizing Rs. 263.53 Crore raised via rights issue. The Audit Committee reviewed the deployment of ₹251.95 Crore for corporate objectives.
Sadhana Nitro Chem Ltd reported revenue from operations of ₹9.1 Cr (-81.6% YoY) and a net loss of ₹33.6 Cr for Q4 FY26.
Sadhana Nitro Chem approved its FY26 audited results and confirmed utilization of ₹251.95 Crore rights issue proceeds. The company reported a net loss for the year.
Sadhana Nitro Chem concluded its EGM on May 22, 2026, to approve capital increases and share issuances. Shareholders considered resolutions for preferential allotment and director appointments.
Sadhana Nitro Chem Limited scheduled a board meeting for May 26, 2026. Directors will consider annual financial results and dividend recommendations for FY2025-26.
Sadhana Nitro Chem Limited reported full utilization of its ₹263.53 Crore rights issue proceeds. The monitoring agency confirmed no deviations in fund usage during the period.
Sadhana Nitro Chem Limited issued a corrigendum for its May 22 EGM regarding a ₹13.91 Crore preferential allotment. Updated disclosures clarify pricing and shareholding patterns.
Sadhana Nitro Chem Limited clarified that its shareholders voted against the dividend recommended by the Board during the September 29, 2025 AGM. Consequently, the previously announced record date of September 22, 2025 has been cancelled.
Sadhana Nitro Chem Limited has published newspaper advertisements regarding its Extra-Ordinary General Meeting (EGM) scheduled for May 22, 2026. The meeting will be held via Video Conferencing to discuss company matters. Notices were published in Financial Express and Mumbai Lakshdeep newspapers.
Sadhana Nitrochem Limited has convened an Extra-ordinary General Meeting on May 22, 2026. Key resolutions include increasing authorized share capital, a preferential allotment of equity shares to private investors, and the appointment/continuation of directors. These actions aim to strengthen the company's capital base and leadership structure.
Sadhana Nitro Chem Limited convened an EGM for May 22, 2026, to approve a ₹13.91 Crore preferential equity allotment to private investors. The agenda also includes increasing authorized share capital to ₹305 Crore, appointing a new Independent Director, and extending the tenure of the Executive Director.
Sadhana Nitrochem Limited has approved a preferential issue of 6.75 crore equity shares to raise ₹13.91 Crore. The issue price is ₹2 per share, with investments from Niraj Bajaj and Poorvi Milan Chitalia. This capital infusion will increase the company's paid-up share capital to ₹303.22 Crore.
Sadhana Nitro Chem Ltd's board approved raising ₹13.91 Crore through a preferential allotment of 6.75 crore shares at ₹2.06 each. The board also proposed increasing the authorized share capital to ₹305 Crore and scheduled an Extraordinary General Meeting for May 22, 2026.
Sadhana Nitrochem Limited has scheduled a board meeting for April 29, 2026. The board will consider increasing the company's authorised capital and raising funds through a preferential issue. The trading window remains closed until June 1, 2026.
Sadhana Nitro Chem Ltd has scheduled a Board Meeting for April 29, 2026. The board will consider raising funds through a preferential issue, increasing authorized share capital, and director appointments. This meeting is a key event for investors to track future capital structure and governance changes.